907 results
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2022 (new)
CHMP, Last updated: 20/05/2022 -
List item
News: First therapy to treat rare genetic nervous system disorder AADC deficiency (new)
CHMP, Last updated: 20/05/2022 -
List item
News: First therapy to treat two types of Niemann-Pick disease, a rare genetic metabolic disorder (new)
CHMP, Last updated: 20/05/2022 -
List item
News: Synchron Research Service: suspension of medicines over flawed studies (new)
CHMP, Last updated: 20/05/2022 -
List item
News: First treatment for children with Progeria or progeroid like syndromes (rare premature aging syndromes) (new)
CHMP, Last updated: 20/05/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2022
CHMP, Last updated: 22/04/2022 -
List item
News: Facilitating global access to diabetes treatments for non-EU patients
CHMP, Last updated: 22/04/2022 -
List item
News: EMA starts review of cancer medicine Rubraca
CHMP, Last updated: 22/04/2022 -
List item
News: EU recommendations for 2022-2023 seasonal flu vaccine composition
CHMP, Last updated: 29/03/2022 -
List item
News: EMA starts rolling review of COVID-19 Vaccine HIPRA (PHH-1V)
CHMP, Last updated: 29/03/2022 -
List item
News: New gene therapy to treat adult patients with multiple myeloma
CHMP, Last updated: 25/03/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 2022
CHMP, Last updated: 25/03/2022 -
List item
News: EMA recommends authorisation of COVID-19 medicine Evusheld
CHMP, Last updated: 24/03/2022 -
List item
News: New medicine for rare type of eye cancer
CHMP, Last updated: 25/02/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022
CHMP, Last updated: 25/02/2022 -
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market (updated)
CMDh, Last updated: 25/05/2022 -
List item
News: EMA recommends authorisation of booster doses of Comirnaty from 12 years of age
CHMP, Last updated: 24/02/2022 -
List item
News: EMA recommends approval of Spikevax for children aged 6 to 11
CHMP, PDCO, Last updated: 24/02/2022 -
List item
News: EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty in adolescents
CHMP, Last updated: 08/02/2022 -
List item
News: New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma
CHMP, Last updated: 28/01/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 02/02/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
News: Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
CHMP, Last updated: 24/01/2022 -
List item
News: COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
CHMP, PRAC, Last updated: 18/01/2022 -
List item
News: EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19
CHMP, PRAC, Last updated: 10/01/2022